These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26038090)

  • 21. Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis.
    Corbera-Bellalta M; García-Martínez A; Lozano E; Planas-Rigol E; Tavera-Bahillo I; Alba MA; Prieto-González S; Butjosa M; Espígol-Frigolé G; Hernández-Rodríguez J; Fernández PL; Roux-Lombard P; Dayer JM; Rahman MU; Cid MC
    Ann Rheum Dis; 2014 Mar; 73(3):616-23. PubMed ID: 23625984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.
    Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P
    Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunohistochemical analysis of fibroblasts in giant cell arteritis.
    Parreau S; Vedrenne N; Regent A; Richard L; Sindou P; Mouthon L; Fauchais AL; Jauberteau MO; Ly KH
    Ann Diagn Pathol; 2021 Jun; 52():151728. PubMed ID: 33798926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.
    Andersson R; Jonsson R; Tarkowski A; Bengtsson BA; Malmvall BE
    Ann Rheum Dis; 1987 Dec; 46(12):915-23. PubMed ID: 2962542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Immunopathology of Giant Cell Arteritis Across Disease Spectra.
    Robinette ML; Rao DA; Monach PA
    Front Immunol; 2021; 12():623716. PubMed ID: 33717128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated Expression of Arterial MicroRNAs and Their Target Gene Networks in Temporal Arteries of Treatment-Naïve Patients with Giant Cell Arteritis.
    Kuret T; Lakota K; Čučnik S; Jurčič V; Distler O; Rotar Ž; Hočevar A; Sodin-Šemrl S; Frank-Bertoncelj M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis.
    Graver JC; Jiemy WF; Altulea DHA; van Sleen Y; Xu S; van der Geest KSM; Verstappen GMPJ; Heeringa P; Abdulahad WH; Brouwer E; Boots AMH; Sandovici M
    J Autoimmun; 2023 Nov; 140():103111. PubMed ID: 37703805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.
    Ly KH; Régent A; Molina E; Saada S; Sindou P; Le-Jeunne C; Brézin A; Witko-Sarsat V; Labrousse F; Robert PY; Bertin P; Bourges JL; Fauchais AL; Vidal E; Mouthon L; Jauberteau MO
    Arthritis Res Ther; 2014 Nov; 16(6):487. PubMed ID: 25418464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
    Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC
    Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella zoster virus triggers the immunopathology of giant cell arteritis.
    Gilden D; Nagel MA
    Curr Opin Rheumatol; 2016 Jul; 28(4):376-82. PubMed ID: 27224742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of interleukin-22 in patients with giant cell arteritis.
    Zerbini A; Muratore F; Boiardi L; Ciccia F; Bonacini M; Belloni L; Cavazza A; Cimino L; Moramarco A; Alessandro R; Rizzo A; Parmeggiani M; Salvarani C; Croci S
    Rheumatology (Oxford); 2018 Jan; 57(1):64-72. PubMed ID: 28968695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.
    Baldini M; Maugeri N; Ramirez GA; Giacomassi C; Castiglioni A; Prieto-González S; Corbera-Bellalta M; Di Comite G; Papa I; Dell'antonio G; Ammirati E; Cuccovillo I; Vecchio V; Mantovani A; Rovere-Querini P; Sabbadini MG; Cid MC; Manfredi AA
    Arthritis Rheum; 2012 Mar; 64(3):854-65. PubMed ID: 21989653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.
    Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Queralt C; Grau JM; Urbano-Márquez A; Palacín A; Colomer D; Cid MC
    Rheumatology (Oxford); 2004 Mar; 43(3):294-301. PubMed ID: 14679293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.
    Schaufelberger C; Andersson R; Nordborg E; Hansson GK; Nordborg C; Wahlström J
    Inflammation; 2008 Dec; 31(6):372-83. PubMed ID: 18975064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
    Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
    Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Arterial Histopathology and microRNA Expression That Underlie Ultrasonography Findings in Temporal Arteries of Patients with Giant Cell Arteritis.
    Suljič A; Hočevar A; Jurčić V; Bolha L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis.
    Conway R; O'Neill L; McCarthy GM; Murphy CC; Fabre A; Kennedy S; Veale DJ; Wade SM; Fearon U; Molloy ES
    Ann Rheum Dis; 2018 Dec; 77(12):1815-1824. PubMed ID: 30097452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.
    Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Gómez-Vaquero C; Marí-Alfonso B; Miranda-Filloy JA; Narvaez J; Ortego-Centeno N; Vicente EF; Blanco R; Amigo-Diaz E; Fernández-Gutiérrez B; Martin J; González-Gay MA
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S12-6. PubMed ID: 21269573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis.
    Dimitrijevic I; Andersson C; Rissler P; Edvinsson L
    Ophthalmology; 2010 Mar; 117(3):628-36. PubMed ID: 20036012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
    Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
    Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.